Skip to main content
. 2021 Aug 24;13:613–622. doi: 10.2147/RRU.S306467

Table 2.

Cox Regression Analysis of Predictors of Acute Kidney Injury Among Cohorts of Type 2 Diabetes Patients at Chronic Follow-Up Clinic of University of Gondar Comprehensive Specialized Hospital, from January 1, 2014, to December 31, 2019 (n= 420)

Variables Survival Status CHR(95% CI) Adjusted AHR(95% CI)
Event Censored
Residence
 Urban 55 188 1.5(0.95, 2.36) 0.33(0.78, 2.17)
 Rural 28 149 1.00 1.00
Smoking habit
 Never smoker 10 14 0.45(0.23, 0.86) 1.06(0.49, 2.30)
 Smoker 73 323 1.00 1.00
Alcohol use
 Yes 44 88 2.746(1.783, 4.23) 1.60(0.97, 2.65)
 No 39 249 1.00 1.00
Hypertension
 Yes 73 154 7.08(3.65, 13.71) 2.87(1.20, 6.90)*
 No 10 181 1.00 1.00
Congestive heart failure
 Yes 53 52 6.61(4.22, 10.37) 2.89(1.62, 5.13)*
 No 30 285 1.00 1.00
Chronic kidney disease
 Yes 30 8 9.03(5.71, 14.27) 2.92(1.56, 5.48)*
 No 53 329 1.00 1.00
Infection
 Yes 68 175 3.71(2.12, 6.50) 1.82(0.95, 3.52)
 No 15 162 1.00 1.00
Stroke
 Yes 14 19 2.71(1.53, 4.82) 1.85(0.95, 3.58)
 No 69 318 1.00 1.00
Diabetic nephropathy
 Yes 43 25 7.13(4.62, 10.99) 2.04(1.13, 3.68)*
 No 40 312 1.00 1.00
Diabetic ketoacidosis
 Yes 24 62 1.83(1.14, 2.95) 1.58(0.91, 2.73)
 No 59 275 1.00 1.00
Diabetic retinopathy
 Yes 14 20 2.27(1.28, 4.04) 0.80(0.38, 1.67)
 No 69 317 1.00 1.00
Diabetic foot ulcer
 Yes 26 56 2.03(1.28, 3.23) 1.10(0.61, 1.97)
 No 57 281 1.00 1.00
Family history of DM
 Yes 31 81 1.84(1.18, 2.88) 0.79(0.46, 1.36)
 No 52 256 1.00 1.00
Beta blockers
 Yes 13 18 2.59(1.43, 4.69) 1.05(0.53, 2.08)
 No 70 319 1.00 1.00
Calcium channel blocker
 Yes 41 61 3.70(2.40, 5.70) 1.22(0.72, 2.08)
 No 42 276 1.00 1.00
ACE inhibitor/ARBs
 Yes 51 124 2.37(1.52, 3.69) 0.85(0.48, 1.48)
 No 32 213 1.00 1.00
Diuretics
 Yes 25 53 1.96(1.22, 3.13) 0.66(0.37, 1.17)
 No 58 284 1.00 1.00
Aminoglycosides
 Yes 14 21 2.24(1.26, 3.97) 1.14(0.59, 2.22)
 No 69 315 1.00 1.00
NSAIDs
 Yes 41 72 2.83(1.84, 4.35) 1.17(0.64, 2.14)
 No 42 265 1.00 1.00
Statin exposure
 Yes 53 139 2.24(1.43, 3.51) 0.94(0.51, 1.72)
 No 30 197 1.00 1.00

Note: *Significant at p<0.05.